Eli Casdin, Director, 10% Owner at STANDARD BIOTOOLS INC. (LAB), bought 1,075,000 shares at $1.30 ($1.4M) on 2025-11-20, disclosed to the SEC on 2025-11-20.
Open-market purchase of $1.4M LAB by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.23 | 275,000 | $338K | 24.7% |
| 2 | $1.28 | 350,000 | $448K | 32.7% |
| 3 | $1.30 | 450,000 | $585K | 42.7% |
| Total | $1.28 avg | 1,075,000 | $1.4M | 100% |
| Filing → |
| LAB | BUY | 2025-08-15 | $604K | — | Filing → |
| BLFS | SELL | 2025-08-13 | $11.3M | — | Filing → |
| BLFS | SELL | 2025-06-12 | $23.8M | — | Filing → |